Meet us at booth #14
Register now for the American Drug Delivery & Formulation Summit (DDF) in Boston and visit us at booth #14. Our team is looking forward to welcoming you and presenting our platform devices for subcutaneous self-administration of large and small molecule drugs.
18 – 19 September, 2023
The Westin Copley Place
Boston, USA
Booth #14
Book an appointment with our expert
Reserve a time slot for a personalized hands-on introduction to our devices with our Sales Manager Ingo Waschulewski PhD. Discover how our solutions respond to patient needs, and can be efficiently adapted to the specifications of your therapeutic drug.
Experience our platform devices for biologics
- The cartridge-based Gx Inbeneo® autoinjector was developed for simple patient usage. It meets the needs of biologic drugs of up to 100 cP and includes features such as a dry needle during storage and push-on-skin activation.
- Gx SensAir® is an on-body injector with a host of features to support patient self-administration in volumes up to 10 ml. It offers on-body detection, 1-button operation, and digital connectivity and its modular design helps minimize waste and save energy through the supply chain.
Experience our platform devices for small molecules
- Delivering a gradual, regular dose of medication over time, our lightweight, compact on-body injector enables the patient to continue with their day. Our modular concept means that the electronics unit is rechargeable and recyclable.
- Our belt-worn injector is designed for 24/7 use with adjustable flowrates and simple user interface for accurate, reliable dosage. It also follows our sustainable, modular concept with a rechargeable electronics unit.
Hear expert insights
Hear from Reza Abedian PhD during his presentation at 12:15 on 19 September. He will discuss:
- The challenges of developing devices for subcutaneous self-administration of large volume and high viscosity medicines
- The importance of early inclusion of voice of patient to ensure devices enhance patient experience
- How a patient-loading concept with reusable/disposable modules eases the supply chain and is more sustainable
Discuss how we collaborate
Talk to our experts about how our solutions reduce time to market and development risk through:
- A platform device concept which facilitates efficient adaptation to the specific requirements of your drug
- Our expertise in medical device development, manufacturing, and regulatory submission
